Asuragen is now Bio-Techne Diagnostics, reflecting our expanded capabilities and continued focus on diagnostic development. Our molecular kits are built on deep technical expertise in amplifying complex genetic targets—enabling detection of hard-to-decipher genes associated with inherited disorders and supporting the evolving needs of haematological malignancy monitoring, and liquid biopsy for solid tumours. Seamlessly compatible with standard lab equipment, the portfolio boosts efficiency, reduces hands‑on time, and helps lower costs—without compromising performance.
